For sales

📢 Highlights from April 01 to 06 in the world of pharma and healthcare! 🗞️👀

Vyuhpharma ResVita Bio (FDA, Orphan Drug Designation) ResVita Bio receives FDA orphan drug esignation for RVB-003 to treat netherton syndrome Novartis (FDA) Novartis receives FDA accelerated approval for VANRAFIA® to reduce proteinuria in IgA nephropathy ESTEVE (Agreement) ESTEVE signs global license and supply agreement with Eton pharmaceuticals for INCRELEX®, excluding the USA Flagship (Partnership) Flagship Pioneering partners with Pfizer to develop novel selective inhibitors for autoimmune diseases GRIN Therapeutics (EmA, PRIME Designation) GRIN Therapeutics granted EMA PRIME designation for Radiprodil in GRIN-related neurodevelopmental disorder
Download

Connect with us

Please fill in the information below, and we'll get back to you.